MON-102 Serum Concentrations of FT4 and TSH in the First Six Months of L-Thyroxine Treatment in Infants with Congenital Hypothyroidism: Target Attainment Rates Should Be Improved

Levo-Thyroxine (L-T4) is the medication of choice for treating congenital hypothyroidism (CH). Adequate L-T4 treatment is essential for early neurodevelopment in affected patients. Both under- and overtreatment with L-T4 were associated with long-term adverse neurological outcomes. Based on clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Leroux, Stéphanie, Pascal, Gächter, Gilbert, Koch, Konrad, Daniel, l’Allemand, Dagmar, Welzel, Tatjana, Pfister, Marc, Szinnai, Gabor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Pediatric Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207872/
http://dx.doi.org/10.1210/jendso/bvaa046.1227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207872/
http://dx.doi.org/10.1210/jendso/bvaa046.1227

Ejemplares similares